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A cooperative dialogue between natural killer (NK) cells and dendritic cells (DCs) has been elucidated in the last years. They help
each other to acquire their complete functions, both in the periphery and in the secondary lymphoid organs. Thus, NK cells’
activation by dendritic cells allows the killing of transformed or infected cells in the periphery but may also be important for
the generation of adaptive immunity. Indeed, it has been shown that NK cells may play a key role in polarizing a Th1 response
upon interaction with DCs exposed to microbial products. This regulatory role of DC/NK cross-talk is of particular importance
at mucosal surfaces such as the intestine, where the immune system exists in intimate association with commensal bacteria such
as lactic acid bacteria (LAB). We here review NK/DC interactions in the presence of gut-derived commensal bacteria and their
role in bacterial strain-dependent immunomodulatory eﬀects. We particularly aim to highlight the ability of distinct species of
commensal bacterial probiotics to diﬀerently aﬀect the outcome of DC/NK cross-talk and consequently to diﬀerently influence the
polarization of the adaptive immune response.
1. Introduction
Dendritic cells (DCs) and natural killer (NK) cells play a
critical role in early defenses against cancer and infections,
and evidence of interactions between these two cell types
has accumulated in the last years [1–7]. This interaction
might results in NK cell activation, DC maturation, or
DC death, depending on the activation status of both cell
types. Thus, the outcome of NK/DC crosstalk is likely to
influence the innate as well as the subsequent adaptive
immune responses [8]. This crosstalk can be promoted
by pathogen-derived products that activate diﬀerent innate
immune cell types directly and simultaneously through their
Toll-like receptors (TLRs) [9]. Indeed, DCs and NK cells
have developed diﬀerent, but partially overlapping, systems
to identify pathogen-associated danger signals and they are,
therefore, diﬀerently involved in the detection of various
microorganisms.
DCs are critical for initiating immune responses against
both pathogenic and nonpathogenic bacteria. In an imma-
ture stage, DCs reside in peripheral tissues, continuously
sampling the microenvironment, sensing the presence of
pathogens, and releasing chemokines and cytokines to
amplify the immune response [10]. It has been clearly evi-
denced that, depending on the nature of the stimuli received,
myeloid DCs can develop into diﬀerent subsets that possess
unique biological functions, determined by the combination
of surface molecule expression and cytokine secretion [10].
In part, these diﬀerent outcomes are influenced by exposure
of the DCs to microbial products. Therefore, the regulatory
role of DCs is of particular importance at mucosal surfaces
such as the intestine, where the immune system exists in
intimate association with the commensal bacteria such as
lactic acid bacteria (LAB) [11]. Interestingly, recent studies
have demonstrated that diﬀerent strains of LAB posses the
ability to finely regulate myeloid DCs maturation, polarizing
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the subsequent T cell activity toward Th1, Th2, or even Treg
responses [12–14].
Natural killer (NK) cells distinguish between normal
healthy cells and abnormal cells by using a sophisticated
repertoire of cell surface receptors [15, 16], playing a key
role in the immune response to certain infections and
malignancies by direct cytolysis of infected or transformed
cells and by secretion of potent immune mediators [7].
Human gut-associated lymphoid tissues harbour various NK
cell subsets, which are certainly involved in maintaining
homeostasis between the intestinal microbiota and the
mucosal immune system [17]. In addition, a human NK-like
cell subset expressing NKp44 and IL-22 but lacking classic
NK cells molecules such as perforin has been more recently
identified [18–20]. Gut-associated NK cells might play
an important role in mucosal homeostasis and protective
immune responses, particularly under microbial challenge.
In addition, although evidence of a direct action of
commensal bacteria, including LAB, on NK cells is still
elusive, recent studies suggested that LAB-induced DC
regulation might aﬀect NK cell activity. It has been reported
that DCs matured by LAB consistently induce activation
and promote proliferation and cytotoxicity in autologous
NK cells, and that strains of diﬀerent LAB species diﬀer
importantly in their capacity to induce IFN-γ production in
NK cells via DCs [14].
This review addresses NK/DC interactions in response
to gut-derived LAB and the implications of LAB strain-
dependent immunomodulatory eﬀects. Finally, we discuss
the potential in vivo impact of commensal bacteria on NK/
DC interplay in mucosal tissues, with particular regard to the
ability of distinct species of commensal bacterial probiotics
to diﬀerently polarize the adaptive immune response.
2. NK-DC Interactions: Molecular Mechanisms
Several in vitro studies show a central role of DC-derived
IL-12, IL-18, and type I IFN in the triggering of NK
cell functions. IL-12 seems to be important to induce the
secretion of IFN-γ by NK cells in several systems: LPS-
activated monocyte-derived DCs, splenic DCs [21, 22], or
poly(I:C)-stimulated myeloid DC [22]. IL-18 may act in
synergy with IL-12 to induce the secretion of IFN-γ by NK
cells but also to enhance cytotoxicity, at least when NK cells
are stimulated with human CD34+ derived DCs [23]. Type I
IFNs have also been shown to enhance cytotoxicity of NK
cells [3, 24]. Although all types of DCs can secrete type I
IFN, the main producer of these cytokines are plasmacytoid
dendritic cells (pDCs), particularly when activated through
TLR7 and TLR9 by virus components [25]. Nevertheless, NK
cells may be activated in an IL-12-, IL-18- and type I IFN-
independent manner. In fact, DCs from IL-12- and IL-18-
deficient mice are able to induce IFN-γ secretion by NK cells.
In mice, this capability might be under the control of IL-2
secreted by bone marrow-derived DCs activated by bacterial
components [26].
IL-15 produced by mature monocyte-derived DCs
appears to be particularly important to stimulate NK
cell proliferation. Interestingly, this eﬀect may require the
membrane-bound form of IL-15, as the proliferation is
abrogated by physical separation of DCs and NK cells [21].
Despite the large mass of data showing the role of
soluble factors in NK cells activation, early studies in mice
suggest the involvement of cell-to-cell contact [1]. Transwell
separation of the two populations could abrogate DC-
dependent NK cells’ cytotoxicity induction [1]. Contact
through an “immunological synapse” may be necessary for
the polarized secretion of IL-12 or of other cytokines by DCs
towardNK cells [27] as well as for ligand-receptor interaction
[28].
Likewise, it is probably through such synaptic formations
that NK cells may kill DCs. Several groups have observed
that NK cells recognize and lyse monocyte-derived DCs in
vitro [2, 29] in a cell-to-cell contact dependentmanner. It has
been described that NK/DC ratio is a critical factor to induce
NK cells-mediated DC death. Whereas a low ratio (1 : 5)
leads to DCs maturation, a higher NK/DC ratio (5 : 1) causes
killing of immature DCs by the autologous NK cells [29].
Interestingly, DC subsets display diﬀerent susceptibilities
to lysis by NK cells; human pDCs were not lysed by IL-
2 activated NK cells whereas mDCs isolated directly from
blood underwent only a limited lysis [22].
Moreover, mature DCs are protected from NK cell lysis
by acquiring a higher expression of HLA I molecules [30].
Beside the inhibitory receptors, NK cells activating receptors
play a primary role in DC targeting. The activating receptor
NKp30 appears to be an important candidate during this
interaction, since the single blocking of this receptor inhibits
NK cell-mediated lysis of immature DCs [2].
In peripheral tissues, the bidirectional crosstalk between
NK cells and DCs has been proposed to play a relevant role
in the mechanisms leading to the selection of DCs with
maximal capability of T cell priming [4, 31]. In particular,
distinct studies have demonstrated that human NK cells have
the capability to induce DC maturation [22, 29, 32]. This
might be important when pathogen-related molecules or
inflammation are not present to drive DC maturation and,
therefore, an eﬀective antigen presentation.
The molecular mechanisms that regulate this specific
part of the human NK/DC crosstalk have been also clarified.
It has been found that, at low NK/DC ratio, NK-DC
interactions induces cytokine production (especially, TNF-α
and IL-12) by DCs as well as the upregulation of a series of
molecules involved in antigen presentation. This stimulating
eﬀect may depend on cell-to-cell contact as well as TNF-α
released by NK cells [29, 32].
3. Crosstalk between NK Cells and
Plasmacytoid DCs
The crosstalk of NK cells with pDCs has not been investigated
as much as with myeloid DCs. Remarkably, NK cells and
pDCs share diﬀerent specific receptors and are thus likely to
respond to similar stimuli and possibly to be involved in the
same phases of the innate immune response [33, 34].
Cytolytic activity of NK cells has long been known to be
enhanced by IFN-α [35], and pDCs, also known as type I
interferon-producing cells [36, 37], have been shown to be
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required for NK cell-mediated lysis of virus-infected target
cells [38].
In humans, the pDC pattern of TLR expression is
profoundly diﬀerent from that of myeloid DCs. pDCs do not
express TLR1, 2, 3, 4, 5, or 6 but express TLR7 that recognizes
viral RNA and TLR9 that recognizes CpG-rich unmethylated
DNA from bacteria and DNA viruses. Signaling by TLRs
expressed on pDCs drives the production of type I IFN that
can directly activate antiviral responses and augment both
innate and adaptive immunity to viral as well as nonviral
infections [25]. Similar to NK cells [39], pDCs express
TLR9. Because both NK cells and pDCs express TLR9, under
appropriate conditions, they can potentially be activated by
the same invading pathogen simultaneously. The abundant
release of type I IFN by pDCs [40], stimulated through
TLR9 [41], suggests that the NK cells/pDCs interaction
can result in enhanced antiviral innate protection. Through
TLR9, the NK/pDC interaction results in upregulation of NK
cell-mediated cytotoxicity against various tumor cell targets
[3, 24, 42]. This eﬀect is strongly reduced by antibodies
against IFN-α, thus indicating a primary role for this
cytokine in regulating NK cell functions [24]. Indeed, a sharp
up-regulation of CD69 surface expression, confirmed that,
under these conditions, NK cells become activated. However,
only the small CD56bright NK cell subset can proliferate in
the presence of pDCs and TLR9 ligands [24]. Nevertheless,
pDC-induced NK cell proliferation appears to be IL-15-
independent since, diﬀerently from monocyte-derived DCs
[21], surface IL-15 is not detectable in TLR-stimulated pDCs
[43]. In turn, NK cells are capable of promoting pDC
maturation and of up-regulating their production of IFN-α
in response to CpG [22]. It is of note that, although NK cells
cannot exert an editing program on pDCs, owing to the poor
susceptibility of these cells to NK cell-mediated lysis, when
cocultured with TLR9-stimulated pDCs, NK cells acquire
lytic activity against monocyte-derived immature DCs [24].
4. Lactic Acid Bacteria and Probiotics
The gastrointestinal tract constitutes an important interface
between host and environment and, as such, has the dual
role of excluding pathogens while facilitating the absorption
of nutrients. It is colonized by an estimated 1014 microbes,
with the density of colonization increasing from the stomach
to the distal colon. Commensal bacteria participate in
both tasks of the gastrointestinal tract: some help in the
absorption of otherwise indigestible nutrients, especially
complex carbohydrates, and some contribute to coloniza-
tion resistance, that is, the ability to inhibit colonization
or overgrowth of allegedly pathogenic microorganisms by
(i) producing antimicrobial substances, (ii) competing for
adhesion sites and nutrients, and (iii) by stimulating the
immune system.
Lactic acid bacteria (LAB) are a group of commen-
sal bacteria characterized by their main metabolite and
comprise bacteria belonging to several genera (Lactococcus,
Streptococcus, Enterococcus, Leuconostoc, and Lactobacillus).
Moreover, the genus Bifidobacterium is often mentioned
in LAB contexts, although the main fermentation product
of bifidobacteria is acetic acid. LAB (hereafter, comprising
bifidobacteria) are predominantly nonpathogenic, Gram
positive, catalase negative, nonsporeforming, facultative
anaerobe, and obligate fermentative. These bacteria have
traditionally been applied in food fermentations due to
their lactic acid production contributing acidity and thereby
prolonged conservation to the foodstuﬀ, and to the pleasant
flavor of other metabolites [44]. Some strains of lactobacilli
and bifidobacteria are acid and bile tolerant and can be
isolated from the mammal gastrointestinal system. In the
stomach and in the upper part of the small intestine,
lactobacilli outnumber other bacteria whereas bifidobacteria
are mainly present in the anaerobic colon, as the dominant
genus in breast-fed infants and in adulthood coexisting with
many other bacterial strains [45]. As a consequence, food
containing viable LAB, such as yoghurt, has gained a reputa-
tion of benefiting intestinal well-being, and LAB strains with
assumed health eﬀects have been termed “probiotic” (prolife,
as opposed to antibiotic). The definition of probiotics
currently employed by the World Health Organization is
“live microorganisms, which when administered in adequate
amounts, confer a health benefit on the host” [46].
“Probiotic” can also designate other microorganisms,
for instance certain strains of E. coli and Saccharomyces
cerevisiae, but the majority of commercial probiotics are LAB
[47]. The eﬀect of LAB on intestinal health can be assigned to
their ability to competitively exclude pathogenic bacteria, to
degrade indigestible food components (i.e., fibre or lactose
in lactose-intolerant individuals) to valuable nutrients, and
finally to support epithelial cell survival and intestinal wall
integrity [48].
Data from studies in gnotobiotic, that is, noncolonized
rodents and rodents with a controlled microbiota, however,
suggest that LAB and other non-pathogenic, so-called com-
mensal, gut bacteria enter in a complex relationship with
their animal host, benefiting health also via interactions
with both the intestinal and the systemic immune system.
If the immune system is not stimulated by gut bacteria
after birth it does not develop completely, comprises fewer
T cells (including Tregs) [49, 50], dendritic cells [51],
and generates weaker antibody responses [52]. Interestingly,
specific recognition of commensal microorganisms occurs
only in the gut and in the mesenteric lymph nodes [53], and
this microbial stimulation might skew the immune system
away from the neonatally dominating Th2 response towards
a balanced Th1 immune profile [54].
5. LAB as Immunomodulators
Individual species of LAB bacteria possess varying immuno-
modulatory properties and may finely polarize the immune
response. LAB mainly exert direct eﬀects on antigen present-
ing cells such as dendritic cells, monocytes, macrophages,
and, to a minor extent, B-cells, without necessarily being
the source of antigen. Cytokines and maturation markers
induced by LAB stimulation on APC are, together with the
type of antigen encountered, determinants of an ensuing
T-cell response [55]. Comparison of stimulation of mono-
cytes/macrophages with LAB as opposed to Gram-negative
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bacteria has shown that LAB preferentially induce IL-12
production whereas Gram-negative bacteria such as E. coli
mainly induce IL-10 [56, 57].
Gastrointestinal-associated lymphoid tissue (GALT) har-
bours two subset of DCs: myeloid DCs (mDCs), expressing
CD11c, and plasmacytoid DCs (pDCs), lacking CD11c and
expressing BDCA-2 and ILT-7 [58]. Since myeloid and
plasmacytoid DCs express diﬀerent repertoires of TLRs, they
are diﬀerently involved in the detection of various pathogens
[59]. LAB stimulation of mDCs yields a complicated picture,
as diﬀerent strains of the same genus or even species of
LAB can induce diﬀerent amounts of IL-10 and IL-12. In
addition to these Th1-Th2/Treg polarizing cytokines, LAB
stimulation frequently leads to TNF-α and IL-6 production
by DCs [60, 61]. Concomitantly with induction of cytokine
production, distinct LAB induce diﬀerent levels of matu-
ration in DCs. Generally, LAB induce “semimature DCs”,
which express lower levels of CD40, CD80, CD86 than DCs
matured with pathogenic Gram-positive bacteria and Gram-
negative bacteria [62], and induction of maturation markers
correlates with their capacity to induce IL-12 and TNF-α.
Among gut-derived LAB, Lactobacillus-dependent induction
of surface markers varies significantly with the strain whereas
most bifidobacteria induce low levels of DC maturation
[14]. The mucosal microbiota might also modulate IFN-α
production by pDCs [63]. Although recent data have shown
that LAB do not directly trigger activation of pDCs, in vitro
studies have suggested a modulation of type I IFN produc-
tion by the mucosal microenvironment on activated pDCs
[63].
How probiotics could modulate activated pDCs remains
an interesting field of investigation: it is hypothesized
that commensal bacteria may act through specific intra-
cytoplasmic TLRs with the help of humoral immunity
or, alternatively, another intriguing scenario may envisage
the cooperation of myeloid DCs in LAB-mediated pDC
regulation [64].
6. Active Components of LAB
Consensus has not been reached regarding whether bacteria
have to survive passage of the gastrointestinal tract to be
termed probiotic. However, a picture is emerging where live
bacteria are obviously required to reach the gut to metabolize
fibres and to outgrow pathogens whereas similar in vitro
immunomodulatory eﬀects of LAB can be obtained with
both live and dead bacteria [13]. For some immunomod-
ulatory eﬀects, cell integrity is required [65], but in other
cases, bacterial components are stimulatory by themselves.
Candidate active molecules of LAB are DNA [66, 67] and
cell wall components [68, 69]. CpG DNA is a ligand of Toll-
like receptor (TLR9) and cell wall peptidoglycan, lipoteichoic
acid, and lipopeptides are recognised by TLR2 in conjunction
with TLR1 or TLR6 [70]. LAB-ligation of TLRs results
in translocation of NFκB to the nucleus with secretion of
proinflammatory cytokines (IL-1β, TNFα, and IL-6) as a
consequence. IL-12 production is also likely to be a product
of TLR-stimulation, as expression of the subunit IL-12p40
in DC in the lamina propria of the small intestine requires
binding of NFκB [71], but also intracellular Nucleotide-
binding oligomerisation domain (NOD) receptors may
recognize LAB peptidoglycan [72, 73]. Regarding the sup-
pressive cytokine IL-10, it can be induced when microbes
are recognised by TLR2 or via C-type lectin receptors such
as DC-SIGN [55]. It is intriguing that, apparently, small
diﬀerences in LAB surface structure result in distinct DCs
maturation and cytokine induction patterns, which function
as a kind of “strain-fingerprint” [74], although for most LAB
these mechanisms still remain poorly understood.
7. LAB Shaping NK/DC Crosstalk
Because LAB have a profound modulatory eﬀect on DCs
and because DCs in turn are potent activators of NK cells,
it is reasonable to expect that DCs that have encountered
LAB and undergo maturation can stimulate NK cells. This
hypothesis has been recently addressed, and it is now clear
that human monocyte-derived DCs [14], blood DCs [75],
mouse splenic [76] and lymph node DCs [77] matured
by IL-12-inducing LAB activate NK cells to produce IFN-
γ, which is in accordance with the belief that IL-12 is
essential for IFN-γ production in NK cells. Similarly, LAB-
stimulated monocytes produce IL-12 and induce IFN-γ
production in NK cells [73–75]. Interestingly, intestine-
near mesenteric lymph node NK cells respond to LAB-
matured DC with a stronger IFN-γ production than their
spleen counterparts [77]. LAB, which do not induce IL-12
in DCs, are equally interesting, because DCs matured by
these LAB do not induce IFN-γ production in NK cells, but,
added together with IL-12-inducing LAB, they reduce IL-12
production by DCs and thereby IFN-γ production by NK
cells. Although the ratio of IL-10/IL-12 induced by non-IL-
12-inducing LAB is high, IL-10 is not responsible for this
suppression [14]. Rather, LAB with diﬀerent properties may
compete for receptor sites including TLR2 [73]. In addition,
when coculturing NK cells with DCs matured by LAB,
irrespective of their IL-12-inducing capacities, increased NK
cell proliferation and cytotoxicity can be observed [14].
Thus, some LAB might actively contribute to Th1 skewing
via the intermediate of NK cells producing IFN-γ whereas a
broader panel of LAB strains may increase NK cell number
and cytotoxic potential owing to their mutual interaction
with dendritic cells (Figure 1).
8. Gut-Derived LAB Induce Species-Dependent
IFN-γ Release by NK Cells via DC Activation
In a study comparing three LAB (L. acidophilus, L. reuteri,
and B. bifidum), only DCs matured by L. acidophilus induced
high amounts of IFN-γ release by NK cells, suggesting that
not all LAB have this capability [14]. It is generally accepted
that IL-12 induces IFN-γ production in human NK cells [4].
IFN-γ production by NK cells is required to induce Th1
responses in lymph nodes [78], emphasizing the importance
of bacterial regulation of IL-12 production in DCs. Remark-
ably, it is still not completely elucidated how L. acidophilus
induces IL-12 production in DCs, although the mechanism
involves recognition by TLR2 [73] and phagocytosis [79].
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Figure 1: Bi-directional activation between dendritic cell and
natural killer (NK) cells in the presence of commensal bacteria.
Immature dendritic cells (iDC) are activated and matured by
commensal bacteria, for example, lactic acid bacteria (LAB). These
LAB-activated mature dendritic cells (DC) produce cytokines able
to activate NK cell cytotoxicity and induce their proliferation.
Activated NK cells can in turn, via the release of relevant cytokines,
recruit (GM-CSF) and activate iDC (TNF-α and IFN-γ). Alterna-
tively, activated NK cells can exert an editing of DC by killing some
of the iDC. At the same time, the early release of IFN-γ by NK
cells interacting with LAB-activated DC, most likely in secondary
lymphoid organs such as the mesenteric lymph nodes, is critical for
shaping the following adaptive immune response toward a type 1
T cell response. Remarkably, some LAB display opposite outcomes
and could hamper T cell type 1 polarization.
This corresponds to Michelsen et al. [80], who showed
that maturation and IL-12 production can be induced in
murine DCs via TLR2 recognizing purified peptidoglycan
and lipoteichoic acid. Of note, IL-12 induction in mDC by
strong IL-12-inducing LAB such as L. acidophilus has recently
been shown to be preceded and partially depend on IFN-
β production by the same cells [79]. How this early IFN-
β production may aﬀect the DC’s interaction with NK cells
remains to be investigated.
Being non-IL-12 inducing LAB strains, B. bifidum and
L. reuteri inhibit L. acidophilus-induced IL-12 production
in DCs and, accordingly, abrogate IFN-γ production by NK
cells [14]. This dominant IL-12-inhibitory property of a
mixture of LAB may be of importance in the intestine where
a large variety of distinct species coexists. The inhibitory
components of these bacteria are seemingly soluble and may
highlight that such compounds reach gut DC compartments
that intact bacteria do not usually access [14, 73].
9. LAB Increasing In Vivo NK Cell
Cytotoxic Potential
A number of probiotic LAB, both IL-12-inducing and non-
IL-12-inducing strains, have been tested for their ability to
increase in vivo NK cell activity as a measure of innate
immune activity. Intervention studies have been conducted
in healthy volunteers, in which the cytolytic potential of
NK cells against standard tumor target cell lines has been
measured at several stages of the intervention. Strong
evidence of an increase in NK cell activity after probiotic
supplementation has been found in elderly individuals [81–
83] and in habitual smokers [84]. Often, the increment in NK
cell cytolytic activity is lost when probiotic supplementation
is terminated [82, 83], reflecting that probiotic bacteria
hardly permanently colonize the host. DCs, and not other
accessory cells, are likely to be the cell type responsible
for the increase in NK cell activity, as DCs present in
Peyer’s patches and the lamina propria of the intestine
have access to the commensal microflora and continuously
migrate to mesenteric lymph nodes [84]. In a human study
comparing intake of fibre and L. casei to reduce recurrence
of colon tumors, L. casei administration was the preferred
intervention [85]. In mice, increased cytolytic potential of
NK cells after ingesting probiotic bacteria has been correlated
to reduction in tumour incidence [86]. In these studies,
however, in addition to a direct eﬀect of NK cells on tumours,
NK cells activation may have promoted Th1 polarization and
thereby a cytotoxic T cell antitumour response. Investigators
have attempted to assign the increase in NK cytolytic activity
to an increase in NK cell number or in per-cell cytotoxicity,
since both phenomena indeed occur [82, 87].
10. Direct Stimulation of NK Cells by LAB
Direct interaction between LAB and NK cells may occur in
the epithelium, where NK cells reside among the intraep-
ithelial lymphocytes [78]. Even if NK cells have previously
been shown to be the lymphocyte population most sensitive
to activation by LAB, it happens only in the presence of
innate accessory cells [88]. These observations, however,
do not rule out that NK cells in the gut may be able
to directly detect LAB, possibly by interaction between
bacterial CpG DNA and TLR9, which is present in NK
cells [39]. Studying the direct eﬀect of LAB stimulation on
both polyclonally activated and nonactivated NK cells, IFN-
γ production was not observed (L.N.F, unpublished data),
suggesting that LAB do not interact with TLR9 on NK
cells, but rather with TLR2 on accessory cells. TLR2 has
been shown to be absent or expressed in low amounts in
NK cells [89, 90], and its ligation only activates NK cells
in the presence of exogenous IL-12 [91]. On the contrary,
induction of cytotoxic activity in NK cells by LAB has been
observed both in the presence and absence of accessory cells
[92].
To our knowledge, only Yun and colleagues [93] have
observed a direct stimulatory eﬀect of gastro-intestinal
bacteria on cytokine production by highly pure NK cells
using Helicobacter pylori. This bacterium may interact with
one of the TLRs shown to be functional in NK cells
recognizing bacterial products: TLR5 that binds flagellin [94]
and TLR9 that detects unmethylated CpG motifs in bacterial
DNA [39], and not TLR2, which is expected to be the main
receptor involved in the recognition of LAB [95].
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11. Role of NK Cells in Th1 Polarization by LAB
Consumption of certain LAB has been shown to alleviate
allergy [96, 97]. Matsuzaki and colleagues [98] observed
that oral administration of Lactobacillus casei, strain Shirota
(LcS), enhance innate immunity by stimulating the activity
of splenic NK cells. Oral feeding with killed LcS was able
to stimulate the production of Th1 cytokines, resulting in
repressed production of IgE antibodies against ovalbumin
in experimental mice. It is believed that LAB skew the
allergic Th2 response to a Th1 response via the induction
of IL-12 in antigen-presenting cells. Interestingly, NK cells
are considered to play a key role in the induction of Th1
responses. It is not known whether NK cells secreting IFN-
γ after interaction with DCs participate in Th1 polarization
by LAB in vivo. Although the link between in vitro and in
vivo activation of NK cells by LAB remains to be established,
LAB may become a valuable tool to promote NK activation
and thereby Th1 polarization, both as oral adjuvants and
as stimulators of DCs exploited in immunotherapy. In
addition, the presence of LAB early in life, deflecting the
immune system towards a Th1 response, possibly through
the intermediate NK cells, may aid in the prevention of
Th2-mediated allergy. Finally, the evidence that weak IFN-γ-
inducing LAB species are able to suppress the action of IFN-
γ-inducing species while preserving NK cell-stimulatory
activity could represent a pivotal mechanism in maintaining
immunological homeostasis in the intestine or for contrast-
ing Th1-mediated autoimmune diseases, such as Crohn’s
disease or even celiac disease. Moreover, LAB may represent
a useful tool for modulating the cytokine balance during
autoimmune diseases driven by Th17 cells in the absence of
IFN-γ [99].
12. Concluding Remarks
Commensal bacteria are known to be involved in the
maintenance of gut immune homeostasis, and now also
emerge as potential NK cell modulators [14]. The crosstalk
between NK cells and DCs suggests a critical role for NK cells
in the initiation and regulation of immune responses. The
considerable knowledge on themolecular basis of these cellu-
lar interactions oﬀers opportunities for clinical intervention
exploiting DC/NK cell cooperation. For instance, LAB
mediate, via DC maturation, proliferation of NK cells and
increase of their cytotoxicity. This indicates that LAB, similar
to pathogenic microorganisms and inflammatory stimuli,
allow DCs to signal to NK cells. Stimulation of NK cell
proliferation and cytotoxicity can, therefore, be considered
a general ability of LAB. An enlarged and more cytolytic
pool of NK cells would be beneficial prophylactically in
healthy individuals but also therapeutically in many disease
conditions.
Purified NK cells rarely respond to commensal bacteria,
and their activation apparently requires the presence of either
pDCs ormyeloid DCs, depending on the stimulus. A concept
emerging from data regarding the crosstalk NK/pDCs is that
type I IFN released by pDCs is a potent inducer of NK
cell cytotoxicity, suggesting that interaction of NK cells with
pDCs can result in enhanced antiviral innate protection.
Furthermore, the mucosal microflora might be able to
regulate IFN-α production by activated pDCs, although
further research is currently highly required in this field of
investigation [63, 64].
More generally, the regulatory role of DCs by LAB
is of particular importance at mucosal surfaces such as
the intestine, where the immune system exists in intimate
association with the commensal bacteria [11]. It has been
shown that diﬀerent species of LAB posses the ability to
finely regulate myeloid DCmaturation and their interactions
with NK cells, polarizing the subsequent T cell activity
toward Th1, Th2, or even Treg responses [12–14]. This
network can, therefore, control not only the strength and the
quality of innate responses but also the subsequent adaptive
responses, via both cell-to-cell interactions and cytokine
release.
In conclusion, LAB potently initiate NK/DC interactions
via DC maturation and, as a consequence of that, NK
cells increase their cytolytic potential. However, diﬀerent
commensal bacteria have diﬀerent eﬀects on IFN-γ pro-
duction by NK cells [14]. Since Th1-promoting LAB or
their inhibitory counterpart (non-IL-12-inducing LAB) can
easily be identified, these LAB strains may represent a useful
tool for modulating the cytokine balance and to promote
potent type-1 immune responses, as required in infection
and cancer, or to contrast immune dysregulation associated
to specific T cell polarization.
All these considerations provide a strong rationale for
a combined targeting of NK cells and LAB-stimulated
DCs in novel immunotherapeutic strategies, exploiting this
cellular crosstalk not only in the treatment of intestinal
inflammatory diseases but also in many other conditions for
which appropriate immune interventions are required.
Acknowledgments
Research in our laboratories is supported by Associazione
Italiana Ricerca sul Cancro (AIRC), and byMinistero Italiano
della Salute—Programma Strategico Ricerca Oncologica. V.
Rizzello, I. Bonaccorsi contributed equally to this study. L.
N. Fink and G. Ferlazzo contributed equally to this study. L.
N. Fink present address is HagedornResearch Institute, Nove
Nordisk A/S, 2820 Gentofte, Denmark.
References
[1] N. C. Fernandez, A. Lozier, C. Flament et al., “Dendritic cells
directly trigger NK cell functions: cross-talk relevant in innate
anti-tumor immune responses in vivo,” Nature Medicine, vol.
5, no. 4, pp. 405–411, 1999.
[2] G. Ferlazzo, M. L. Tsang, L. Moretta, G. Melioli, R. M.
Steinman, and C. Mu¨nz, “Human dendritic cells activate
resting natural killer (NK) cells and are recognized via the
NKp30 receptor by activated NK cells,” Journal of Experimental
Medicine, vol. 195, no. 3, pp. 343–351, 2002.
[3] F. Gerosa, B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra,
and G. Trinchieri, “Reciprocal activating interaction between
natural killer cells and dendritic cells,” Journal of Experimental
Medicine, vol. 195, no. 3, pp. 327–333, 2002.
Journal of Biomedicine and Biotechnology 7
[4] A.Moretta, “Natural killer cells and dendritic cells: rendezvous
in abused tissues,” Nature Reviews Immunology, vol. 2, no. 12,
pp. 957–964, 2002.
[5] M. A. Cooper, T. A. Fehniger, A. Fuchs, M. Colonna, and
M. A. Caligiuri, “NK cell and DC interactions,” Trends in
Immunology, vol. 25, no. 1, pp. 47–52, 2004.
[6] G. Ferlazzo and C. Mu¨nz, “NK cell compartments and their
activation by dendritic cells,” Journal of Immunology, vol. 172,
no. 3, pp. 1333–1339, 2004.
[7] L. Moretta, G. Ferlazzo, C. Bottino et al., “Eﬀector and regu-
latory events during natural killer-dendritic cell interactions,”
Immunological Reviews, vol. 214, no. 1, pp. 219–228, 2006.
[8] C. E. Andoniou, S. L. H. van Dommelen, V. Voigt et al.,
“Interaction between conventional dendritic cells and natural
killer cells is integral to the activation of eﬀective antiviral
immunity,”Nature Immunology, vol. 6, no. 10, pp. 1011–1019,
2005.
[9] S. Akira and K. Takeda, “Toll-like receptor signaling,” Nature
Reviews Immunology, vol. 4, pp. 499–511, 2004.
[10] J. Banchereau and R. M. Steinman, “Dendritic cells and the
control of immunity,” Nature, vol. 392, no. 6673, pp. 245–252,
1998.
[11] A. J. Stagg, A. L. Hart, S. C. Knight, and M. A. Kamm,
“Microbial-gut interactions in health and disease. Interactions
between dendritic cells and bacteria in the regulation of
intestinal immunity,” Best Practice and Research Clinical
Gastroenterology, vol. 18, no. 2, pp. 255–270, 2004.
[12] H. R. Christensen, H. Frøkiær, and J. J. Pestka, “Lactobacilli
diﬀerentially modulate expression of cytokines and matura-
tion surface markers in murine dendritic cells,” Journal of
Immunology, vol. 168, no. 1, pp. 171–178, 2002.
[13] L. H. Zeuthen, H. R. Christensen, and H. Frøkiær, “Lactic acid
bacteria inducing a weak interleukin-12 and tumor necrosis
factor alpha response in human dendritic cells inhibit strongly
stimulating lactic acid bacteria but act synergistically with
gram-negative bacteria,”Clinical and Vaccine Immunology, vol.
13, no. 3, pp. 365–375, 2006.
[14] L. N. Fink, L. H. Zeuthen, H. R. Christensen, B. Morandi,
H. Frøkiær, and G. Ferlazzo, “Distinct gut-derived lactic
acid bacteria elicit divergent dendritic cell-mediated NK cell
responses,” International Immunology, vol. 19, no. 12, pp.
1319–1327, 2007.
[15] G. Trinchieri, “Biology of natural killer cells,” Advances in
Immunology, vol. 47, pp. 187–376, 1989.
[16] A. Moretta, C. Bottino, M. Vitale et al., “Activating recep-
tors and coreceptors involved in human natural killer cell-
mediated cytolysis,”Annual Review of Immunology, vol. 19, pp.
197–223, 2001.
[17] J. P. Di Santo, C. A. Vosshenrich, and N. Satoh-Takayama, “A
‘natural’ way to provide innate mucosal immunity,” Current
Opinion in Immunology, vol. 22, no. 4, pp. 435–441, 2010.
[18] M. Cella, A. Fuchs, W. Vermi et al., “A human natural killer
cell subset provides an innate source of IL-22 for mucosal
immunity,” Nature, vol. 457, no. 7230, pp. 722–725, 2009.
[19] S. L. Sanos, V. L. Bui, A. Mortha et al., “RORγt and commensal
microflora are required for the diﬀerentiation of mucosal
interleukin 22-producing NKp46+ cells,” Nature Immunology,
vol. 10, no. 1, pp. 83–91, 2009.
[20] C. Luci, A. Reynders, I. I. Ivanov et al., “Influence of the
transcription factor RORγt on the development of NKp46+
cell populations in gut and skin,” Nature Immunology, vol. 10,
no. 1, pp. 75–82, 2009.
[21] G. Ferlazzo, M. Pack, D. Thomas et al., “Distinct roles of IL-12
and IL-15 in human natural killer cell activation by dendritic
cells from secondary lymphoid organs,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 101, no. 47, pp. 16606–16611, 2004.
[22] F. Gerosa, A. Gobbi, P. Zorzi et al., “The reciprocal interaction
of NK cells with plasmacytoid or myeloid dendritic cells
profoundly aﬀects innate resistance functions,” Journal of
Immunology, vol. 174, no. 2, pp. 727–734, 2005.
[23] Y. Yu, M. Hagihara, K. Ando et al., “Enhancement of human
cord blood CD34 cell-derived NK cell cytotoxicity by dendritic
cells,” Journal of Immunology, vol. 166, no. 3, pp. 1590–1600,
2001.
[24] C. Romagnani, M. Della Chiesa, S. Kohler et al., “Activation
of human NK cells by plasmacytoid dendritic cells and its
modulation by CD4 T helper cells and CD4+ CD25+ T
regulatory cells,” European Journal of Immunology, vol. 35, no.
8, pp. 2452–2458, 2005.
[25] M. Colonna, G. Trinchieri, and Y. J. Liu, “Plasmacytoid
dendritic cells in immunity,” Nature Immunology, vol. 5, no.
12, pp. 1219–1226, 2004.
[26] F. Granucci, S. Feau, V. Angeli, F. Trottein, and P. Ricciardi-
Castagnoli, “Early IL-2 production by mouse dendritic cells is
the result of microbial-induced priming,” Journal of Immunol-
ogy, vol. 170, no. 10, pp. 5075–5081, 2003.
[27] C. Borg, A. Jalil, D. Laderach et al., “NK cell activation by
dendritic cells (DCs) requires the formation of a synapse
leading to IL-12 polarization in DCs,” Blood, vol. 104, no. 10,
pp. 3267–3275, 2004.
[28] Y. M. Vyas, H. Maniar, and B. Dupont, “Visualization of
signaling pathways and cortical cytoskeleton in cytolytic and
noncytolytic natural killer cell immune synapses,” Immuno-
logical Reviews, vol. 189, pp. 161–178, 2002.
[29] D. Piccioli, S. Sbrana, E. Melandri, and N. M. Valiante,
“Contact-dependent stimulation and inhibition of dendritic
cells by natural killer cells,” Journal of Experimental Medicine,
vol. 195, no. 3, pp. 335–341, 2002.
[30] G. Ferlazzo, C. Semino, and G. Melioli, “HLA Class I molecule
expression is up-regulated during maturation of dendritic
cells, protecting them from natural killer cell-mediated lysis,”
Immunology Letters, vol. 76, no. 1, pp. 37–41, 2001.
[31] R. B. Mailliard, Y. I. Son, R. Redlinger et al., “Dendritic cells
mediate NK cell help for Th1 and CTL responses: two-signal
requirement for the induction of NK cell helper function,”
Journal of Immunology, vol. 171, no. 5, pp. 2366–2373, 2003.
[32] B. Morandi, L. Mortara, P. Carrega et al., “NK cells provide
helper signal for CD8+ T cells by inducing the expression of
membrane-bound IL-15 on DCs,” International Immunology,
vol. 21, no. 5, pp. 599–606, 2009.
[33] A. Fuchs, M. Cella, T. Kondo, and M. Colonna, “Paradoxic
inhibition of human natural interferon-producing cells by the
activating receptor NKp44,” Blood, vol. 106, no. 6, pp. 2076–
2082, 2005.
[34] I. Bonaccorsi, C. Cantoni, P. Carrega et al., “The immune
inhibitory receptor LAIR-1 is highly expressed by plasmacy-
toid dendritic cells and acts complementary with NKp44 to
control IFNα production,” PLoS One, vol. 5, no. 11, article
15080, 2010.
[35] G. Trinchieri andD. Santoli, “Antiviral activity induced by cul-
turing lymphocytes with tumor-derived or virus-transformed
cells. Enhancement of human natural killer cell activity by
interferon and antagonistic inhibition of susceptibility of
target cells to lysis,” Journal of Experimental Medicine, vol. 147,
no. 5, pp. 1314–1333, 1978.
[36] B. Perussia, V. Fanning, and G. Trinchieri, “A leukocyte
subset bearing HLA-DR antigens is responsible for in vitro
8 Journal of Biomedicine and Biotechnology
alpha interferon production in response to viruses,” Natural
Immunity and Cell Growth Regulation, vol. 4, no. 3, pp. 120–
137, 1985.
[37] F. P. Siegal, N. Kadowaki, M. Shodell et al., “The nature of the
principal Type 1 interferon-producing cells in human blood,”
Science, vol. 284, no. 5421, pp. 1835–1837, 1999.
[38] S. Bandyopadhyay, B. Perussia, and G. Trinchieri, “Require-
ment for HLA-DR+ accessory cells in natural killing of
cytomegalovirus-infected fibroblasts,” Journal of Experimental
Medicine, vol. 164, no. 1, pp. 180–195, 1986.
[39] S. Sivori, M. Falco, M. Della Chiesa et al., “CpG and double-
stranded RNA trigger human NK cells by toll-like receptors:
induction of cytokine release and cytotoxicity against tumors
dendritic cells,” Proceedings of the National Academy of Sciences
of the United States of America, vol. 101, no. 27, pp. 10116–
10121, 2004.
[40] C. Asselin-Paturel and G. Trinchieri, “Production of type I
interferons: plasmacytoid dendritic cells and beyond,” Journal
of Experimental Medicine, vol. 202, no. 4, pp. 461–465, 2005.
[41] A. M. Krieg, “CpG motifs in bacterial DNA and their immune
eﬀects,” Annual Review of Immunology, vol. 20, pp. 709–760,
2002.
[42] D. Schepis, I. Gunnarsson, M. L. Eloranta et al., “Increased
proportion of CD56 natural killer cells in active and inactive
systemic lupus erythematosus,” Immunology, vol. 126, no. 1,
pp. 140–146, 2009.
[43] M. Jinushi, T. Takehara, T. Tatsumi et al., “Autocrine/paracrine
IL-15 that is required for type I IFN-mediated dendritic cell
expression of MHC class I-related chain A and B is impaired
in hepatitis C virus infection,” Journal of Immunology, vol. 171,
no. 10, pp. 5423–5429, 2003.
[44] F. Guarner and G. J. Schaafsma, “Probiotics,” International
Journal of Food Microbiology, vol. 39, no. 3, pp. 237–238, 1998.
[45] H. J. M. Harmsen, A. C. M. Wildeboer-Veloo, G. C. Raangs
et al., “Analysis of intestinal flora development in breast-fed
and formula-fed infants by using molecular identification and
detection methods,” Journal of Pediatric Gastroenterology and
Nutrition, vol. 30, no. 1, pp. 61–67, 2000.
[46] M. Araya, L. Morelli, G. Reid, M. E. Sanders, and C. Stanton,
“Guidelines for the evaluaton of probiotics in food,” Report
of a Joint FAO/WHO working group on drafting guidelines
for the evaluation of probiotics in food, London, Ontario,
Canada, 2002.
[47] W. H. Holzapfel, P. Haberer, J. Snel, U. Schillinger, and J.
H. J. Huis In’t Veld, “Overview of gut flora and probiotics,”
International Journal of Food Microbiology, vol. 41, no. 2, pp.
85–101, 1998.
[48] A. C. Ouwehand, S. Salminen, and E. Isolauri, “Probiotics: an
overview of beneficial eﬀects,” Antonie van Leeuwenhoek, vol.
82, no. 1–4, pp. 279–289, 2002.
[49] S. O¨stman, C. Rask, A. E. Wold, S. Hultkrantz, and E. Telemo,
“Impaired regulatory T cell function in germ-free mice,”
European Journal of Immunology, vol. 36, no. 9, pp. 2336–2346,
2006.
[50] S. K. Mazmanian, H. L. Cui, A. O. Tzianabos, and D.
L. Kasper, “An immunomodulatory molecule of symbiotic
bacteria directs maturation of the host immune system,” Cell,
vol. 122, no. 1, pp. 107–118, 2005.
[51] K. L. W. Walton, J. He, B. L. Kelsall, R. B. Sartor, and N. C.
Fisher, “Dendritic cells in germ-free and specific pathogen-
free mice have similar phenotypes and in vitro antigen
presenting function,” Immunology Letters, vol. 102, no. 1, pp.
16–24, 2006.
[52] M. V. Herı´as, C. Hessle, E. Telemo, T. Midtvedt, L. A˚. Hanson,
and A. E. Wold, “Immunomodulatory eﬀects of Lactobacillus
plantarum colonizing the intestine of gnotobiotic rats,” Clini-
cal and Experimental Immunology, vol. 116, no. 2, pp. 283–290,
1999.
[53] A. J. Macpherson and T. Uhr, “Induction of protective IgA
by intestinal dendritic cells carrying commensal bacteria,”
Science, vol. 303, no. 5664, pp. 1662–1665, 2004.
[54] M. Bailey, K. Haverson, C. Inman et al., “The development of
themucosal immune system pre- and post-weaning: balancing
regulatory and eﬀector function,” Proceedings of the Nutrition
Society, vol. 64, no. 4, pp. 451–457, 2005.
[55] M. L. Kapsenberg, “Dendritic-cell control of pathogen-driven
T-cell polarization,” Nature Reviews Immunology, vol. 3, no.
12, pp. 984–993, 2003.
[56] M. L. Cross, A. Ganner, D. Teilab, and L. M. Fray, “Patterns of
cytokine induction by gram-positive and gram-negative pro-
biotic bacteria,” FEMS Immunology and Medical Microbiology,
vol. 42, no. 2, pp. 173–180, 2004.
[57] C. Hessle, B. Andersson, and A. E. Wold, “Gram-positive
bacteria are potent inducers of monocytic interleukin-12 (IL-
12) while gram-negative bacteria preferentially stimulate IL-10
production,” Infection and Immunity, vol. 68, no. 6, pp. 3581–
3586, 2000.
[58] J. Schettini and P. Mukherjee, “Physiological role of plas-
macytoid dendritic cells and their potential use in cancer
immunity,” Clinical and Developmental Immunology, vol.
2008, Article ID 106321, 10 pages, 2008.
[59] T. T. MacDonald and J. N. Gordon, “Bacterial regulation
of intestinal immune responses,” Gastroenterology Clinics of
North America, vol. 34, no. 3, pp. 401–412, 2005.
[60] L. H. Zeuthen, L. N. Fink, and H. Frokiaer, “Epithelial
cells prime the immune response to an array of gut-derived
commensals towards a tolerogenic phenotype through distinct
actions of thymic stromal lymphopoietin and transforming
growth factor-β,” Immunology, vol. 123, no. 2, pp. 197–208,
2008.
[61] M. Mohamadzadeh, S. Olson, W. V. Kalina et al., “Lactobacilli
active human dendritic cells that skew T cells toward T helper
1 polarization,” Proceedings of the National Academy of Sciences
of the United States of America, vol. 102, no. 8, pp. 2880–2885,
2005.
[62] V. Veckman,M.Miettinen, J. Pirhonen, J. Sire´n, S.Matikainen,
and I. Julkunen, “Streptococcus pyogenes and Lactobacillus
rhamnosus diﬀerentially induce maturation and production
of Th1-type cytokines and chemokines in human monocyte-
derived dendritic cells,” Journal of Leukocyte Biology, vol. 75,
no. 5, pp. 764–771, 2004.
[63] N. Contractor, J. Louten, L. Kim, C. A. Biron, and B. L.
Kelsall, “Cutting edge: peyer’s patch plasmacytoid dendritic
cells (pDCs) produce low levels of type I interferons: possible
role for IL-10, TGFβ, and prostaglandin E in conditioning a
unique mucosal pDC phenotype,” Journal of Immunology, vol.
179, no. 5, pp. 2690–2694, 2007.
[64] D. Piccioli, C. Sammicheli, S. Tavarini et al., “Human plasma-
cytoid dendritic cells are unresponsive to bacterial stimulation
and require a novel type of cooperation withmyeloid dendritic
cells for maturation,” Blood, vol. 113, no. 18, pp. 4232–4239,
2009.
[65] H. H. Smits, A. J. van Beelen, C. Hessle et al., “Commensal
Gram-negative bacteria prime human dendritic cells for
enhanced IL-23 and IL-27 expression and enhanced Th1
development,” European Journal of Immunology, vol. 34, no.
5, pp. 1371–1380, 2004.
Journal of Biomedicine and Biotechnology 9
[66] D. Rachmilewitz, K. Katakura, F. Karmeli et al., “Toll-like
receptor 9 signaling mediates the anti-inflammatory eﬀects of
probiotics in murine experimental colitis,” Gastroenterology,
vol. 126, no. 2, pp. 520–528, 2004.
[67] K. M. Lammers, P. Brigidi, B. Vitali et al., “Immunomod-
ulatory eﬀects of probiotic bacteria DNA: IL-1 and IL-10
response in human peripheral blood mononuclear cells,”
FEMS Immunology and Medical Microbiology, vol. 38, no. 2,
pp. 165–172, 2003.
[68] C. Grangette, S. Nutten, E. Palumbo et al., “Enhanced antiin-
flammatory capacity of a Lactobacillus plantarummutant syn-
thesizing modified teichoic acids,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 102,
no. 29, pp. 10321–10326, 2005.
[69] T. Chen, P. Isoma¨ki, M. Rimpila¨inen, and P. Toivanen,
“Human cytokine responses induced by Gram-positive cell
walls of normal intestinal microbiota,” Clinical and Experi-
mental Immunology, vol. 118, no. 2, pp. 261–267, 1999.
[70] H. Heine and E. Lien, “Toll-like receptors and their function
in innate and adaptive immunity,” International Archives of
Allergy and Immunology, vol. 130, no. 3, pp. 180–192, 2003.
[71] C. Becker, S. Wirtz, M. Blessing et al., “Constitutive p40 pro-
moter activation and IL-23 production in the terminal ileum
mediated by dendritic cells,” Journal of Clinical Investigation,
vol. 112, no. 5, pp. 693–706, 2003.
[72] D. J. Philpott and S. E. Girardin, “The role of Toll-like
receptors and Nod proteins in bacterial infection,” Molecular
Immunology, vol. 41, no. 11, pp. 1099–1108, 2004.
[73] L. H. Zeuthen, L. N. Fink, and H. Frøkiær, “Toll-like receptor
2 and nucleotide-binding oligomerization domain-2 play
divergent roles in the recognition of gut-derived lactobacilli
and bifidobacteria in dendritic cells,” Immunology, vol. 124,
no. 4, pp. 489–502, 2008.
[74] S. R. Konstantinov, H. Smidt, W. M. De Vos et al., “S
layer protein A of Lactobacillus acidophilus NCFM regulates
immature dendritic cell and T cell functions,” Proceedings
of the National Academy of Sciences of the United States of
America, vol. 105, no. 49, pp. 19474–19479, 2008.
[75] L. N. Fink, L. H. Zeuthen, G. Ferlazzo, and H. Frøkiær,
“Human antigen-presenting cells respond diﬀerently to
gut-derived probiotic bacteria but mediate similar strain-
dependent NK and T cell activation,” FEMS Immunology and
Medical Microbiology, vol. 51, no. 3, pp. 535–546, 2007.
[76] S. I. Koizumi, D. Wakita, T. Sato et al., “Essential role of Toll-
like receptors for dendritic cell and NK1.1+ cell-dependent
activation of type 1 immunity by Lactobacillus pentosus strain
S-PT84,” Immunology Letters, vol. 120, no. 1-2, pp. 14–19,
2008.
[77] L. N. Fink and H. Frøkiær, “Dendritic cells from Peyer’s
patches and mesenteric lymph nodes diﬀer from spleen
dendritic cells in their response to commensal gut bacteria,”
Scandinavian Journal of Immunology, vol. 68, no. 3, pp. 270–
279, 2008.
[78] F. Leon, E. Roldan, L. Sanchez, C. Camarero, A. Bootello,
and G. Roy, “Human small-iintestinal epithelium contains
functional natural killer lymphocytes,” Gastroenterology, vol.
125, no. 2, pp. 345–356, 2003.
[79] G. Weiss, S. Rasmussen, L. H. Zeuthen et al., “Lactobacillus
acidophilus induces virus immune defence genes in murine
dendritic cells by a Toll-like receptor-2-dependent mecha-
nism,” Immunology, vol. 131, no. 2, pp. 268–281, 2010.
[80] K. S. Michelsen, A. Aicher, M. Mohaupt et al., “The role of
toll-like receptors (TLRs) in bacteria-induced maturation of
murine dendritic cells (DCs),” Journal of Biological Chemistry,
vol. 276, no. 28, pp. 25680–25686, 2001.
[81] K. Takeda, T. Suzuki, S. I. Shimada, K. Shida, M. Nanno, and
K. Okumura, “Interleukin-12 is involved in the enhancement
of human natural killer cell activity by Lactobacillus casei
Shirota,” Clinical and Experimental Immunology, vol. 146, no.
1, pp. 109–115, 2006.
[82] H. S. Gill, K. J. Rutherfurd, M. L. Cross, and P. K. Gopal,
“Enhancement of immunity in the elderly by dietary supple-
mentation with the probiotic Bifidobactedum lactis HN019,”
American Journal of Clinical Nutrition, vol. 74, no. 6, pp. 833–
839, 2001.
[83] H. S. Gill, K. J. Rutherfurd, and M. L. Cross, “Dietary
probiotic supplementation enhances natural killer cell activity
in the elderly: an investigation of age-related immunological
changes,” Journal of Clinical Immunology, vol. 21, no. 4, pp.
264–271, 2001.
[84] K. Morimoto, T. Takeshita, M. Nanno, S. Tokudome, and
K. Nakayama, “Modulation of natural killer cell activity by
supplementation of fermented milk containing Lactobacillus
casei in habitual smokers,” Preventive Medicine, vol. 40, no. 5,
pp. 589–594, 2005.
[85] H. Ishikawa, I. Akedo, T. Otani et al., “Randomized trial
of dietary fiber and Lactobacillus casei administration for
prevention of colorectal tumors,” International Journal of
Cancer, vol. 116, no. 5, pp. 762–767, 2005.
[86] J. H. Niess and H. C. Reinecker, “Dendritic cells: the
commanders-in-chief of mucosal immune defenses,” Current
Opinion in Gastroenterology, vol. 22, no. 4, pp. 354–360, 2006.
[87] A. Takagi, T. Matsuzaki, M. Sato, K. Nomoto, M. Morotomi,
and T. Yokokura, “Enhancement of natural killer cytotoxicity
delayed murine carcinogenesis by a probiotic microorganism,”
Carcinogenesis, vol. 22, no. 4, pp. 599–605, 2001.
[88] D. Haller, S. Blum, C. Bode, W. P. Hammes, and E. J. Schiﬀrin,
“Activation of human peripheral blood mononuclear cells
by nonpathogenic bacteria in vitro: evidence of NK cells as
primary targets,” Infection and Immunity, vol. 68, no. 2, pp.
752–759, 2000.
[89] M. Muzio, D. Bosisio, N. Polentarutti et al., “Diﬀerential
expression and regulation of toll-like receptors (TLR) in
human leukocytes: selective expression of TLR3 in dendritic
cells,” Journal of Immunology, vol. 164, no. 11, pp. 5998–6004,
2000.
[90] V. Hornung, S. Rothenfusser, S. Britsch et al., “Quantitative
expression of toll-like receptor 1-10 mRNA in cellular subsets
of human peripheral blood mononuclear cells and sensitivity
to CpG oligodeoxynucleotides,” Journal of Immunology, vol.
168, no. 9, pp. 4531–4537, 2002.
[91] J. Sawaki, H. Tsutsui, N. Hayashi et al., “Type 1 cytokine/
chemokine production by mouse NK cells following activa-
tion of their TLR/MyD88-mediated pathways,” International
Immunology, vol. 19, no. 3, pp. 311–320, 2007.
[92] S. Cheon, K.W. Lee, K. E. Kim et al., “Heat-killed Lactobacillus
acidophilus La205 enhances NK cell cytotoxicity through
increased granule exocytosis,” Immunology Letters, vol. 136,
no. 2, pp. 171–176.
[93] C. H. Yun, A. Lundgren, J. Azem et al., “Natural killer
cells and Helicobacter pylori infection: bacterial antigens and
interleukin-12 act synergistically to induce gamma interferon
production,” Infection and Immunity, vol. 73, no. 3, pp. 1482–
1490, 2005.
[94] A. Chalifour, P. Jeannin, J. F. Gauchat et al., “Direct bacterial
protein PAMPs recognition by human NK cells involves TLRs
10 Journal of Biomedicine and Biotechnology
and triggers α-defensin production,” Blood, vol. 104, pp. 1778–
1783, 2004.
[95] H. Karlsson, P. Larsson, A. E. Wold, and A. Rudin, “Pattern
of cytokine responses to gram-positive and gram-negative
commensal bacteria is profoundly changed when monocytes
diﬀerentiate into dendritic cells,” Infection and Immunity, vol.
72, no. 5, pp. 2671–2678, 2004.
[96] M. Kallioma¨ki, S. Salminen, H. Arvilommi, P. Kero, P.
Koskinen, and E. Isolauri, “Probiotics in primary prevention
of atopic disease: a randomised placebo-controlled trial,”
Lancet, vol. 357, no. 9262, pp. 1076–1079, 2001.
[97] D. Fujiwara, S. Inoue, H. Wakabayashi, and T. Fujii, “The anti-
allergic eﬀects of lactic acid bacteria are strain dependent and
mediated by eﬀects on both Th1/Th2 cytokine expression and
balance,” International Archives of Allergy and Immunology,
vol. 135, no. 3, pp. 205–215, 2004.
[98] T. Matsuzaki and J. Chin, “Modulating immune responses
with probiotic bacteria,” Immunology and Cell Biology, vol. 78,
no. 1, pp. 67–73, 2000.
[99] L. E. Harrington, R. D. Hatton, P. R. Mangan et al.,
“Interleukin 17-producing CD4+ eﬀector T cells develop via
a lineage distinct from the T helper type 1 and 2 lineages,”
Nature Immunology, vol. 6, no. 11, pp. 1123–1132, 2005.
